N2b期偏侧扁桃体癌同侧颈部放疗——需谨慎对待
单中心回顾性系列纳入2004至2011年接受同侧颈部放疗的偏侧扁桃体癌患者53例,对侧颈部复发率7.5%(4/53),4例均为p16阳性T1N2bM0;N2b亚组(28/53)对侧颈部复发率14.3%。随后改为N2b患者双侧颈部IMRT,23例中未观察到对侧颈部复发。
要点
- N2b偏侧扁桃体癌同侧颈部放疗后对侧颈部复发率14.3%(4/28)。
- 4例对侧颈部复发均为p16阳性、T1、N2b、M0肿瘤。
- N2b患者改用双侧颈部IMRT后23例中未观察到对侧颈部复发。
核心结论
- 在N2b人群中观察到高于预期的对侧颈部复发率,对这些患者采用双侧颈部IMRT是安全的替代方案。
研究设计与样本
- 单中心回顾性系列,纳入2004至2011年间接受同侧颈部放疗的偏侧扁桃体癌患者53例。
- 随后分析23例接受双侧颈部调强放疗(IMRT)的N2b患者结局。
主要发现
- 53例接受同侧颈部放疗的患者中对侧颈部复发率为7.5%(4/53)。
- 4例对侧颈部复发患者均为p16阳性、T1、N2b、M0肿瘤。
- N2b亚组(28/53)对侧颈部复发率为14.3%。
- 23例N2b患者接受双侧颈部IMRT后未观察到对侧颈部复发。
临床怎么用
- 作者观察到N2b人群对侧颈部复发率高于预期,认为对N2b患者采用双侧颈部IMRT是安全的替代方案。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Treatment of the uninvolved neck in well-lateralized tonsillar squamous cell carcinoma is controversial. We became concerned after a number of contralateral neck recurrences (CNRs) in patients receiving ipsilateral radiotherapy (RT). METHODS: This is a single center retrospective series including patients with well-lateralized tonsillar cancer treated with ipsilateral neck RT between 2004 and 2011. RESULTS: We identified 53 patients treated with ipsilateral neck RT during the study period. The rate of CNR was 7.5% (4 of 53). All four patients had p16-positive, T1, N2b, M0 tumors. The subgroup of patients with N2b disease (28 of 53) had a CNR of 14.3%. We subsequently switched to treat patients with N2b with bilateral neck RT. We analyzed the outcomes of 23 patients with N2b treated with bilateral neck intensity-modulated RT (IMRT) and observed no CNRs. CONCLUSIONS: We observed a higher than expected rate of CNR in the N2b population. Bilateral neck IMRT for these patients represents a safe alternative.
引用
- Maskell D, Buckley H, Sission K, et al. Ipsilateral neck radiotherapy in N2b well-lateralized tonsil cancer - Approach with caution. Head Neck. 2019. PMID: 31059180. doi:10.1002/hed.25776
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。